Qualitative assessment of human exposure to consumption of injection site residues

The recent adoption of the guideline on injection site residues in food producing animals by the Committee for Medicinal Products for Veterinary Use (CVMP) raised the question on the risk specifically related to injection site consumption. As noted in this guideline, residues at injection sites commonly deplete erratically. For the calculation of withdrawal time, treating residues at the injection site like those that occur in other tissues is questionable. An assessment of the risk related to the consumption of a whole or part of an injection site during a year was performed using a probabilistic approach. The risk assessment was modelled on the regimen of a 7-day antibiotic treatment, and was calculated on the scale of the European Union (EU) as a whole or of each European country. Our analysis indicated a maximal risk of 4 days of injection site consumption during a year in the EU. It also indicated that 37% of consumers would never eat an injection site in the same period. These results suggest that the risk of injection site consumption belongs more appropriately to an acute exposure risk than to a chronic one which is usually posed by the residues present in other edible tissues.     

Nasal chondrosarcoma in a Simmental cow

The pathologic features of a nasal chondrosarcoma, a rare tumor of bovines, in a Simmental cow are described. Upon clinical examination, stertor, difficulty in breathing, poor body condition, and a nasal mass were found. Histopathologic examination revealed that the mass was composed mostly of numerous cartilaginous lobules surrounded by spindle-shaped cells, often showing mitotic figures, atypical chondrocytes, and lacunae containing 2 or more cells. On the basis of the histological features, the mass was diagnosed as a nasal chondrosarcoma.     

Assessment of novel inhibitors of Helicoverpa aminopeptidases as anti-insect agents

Helicoverpa species present problems worldwide as pests on a variety of agricultural crops. In Australia, the costs of controlling H. armigera (Hübn.) and H. punctigera (Wall.) are a major burden on the cotton industry, and novel mechanisms are continually sought to combat these pests. Potential new targets for insecticides are the digestive proteases of the insect, including the aminopeptidases (APs). A variety of compounds, designed to be similar in structure to known AP inhibitors, were synthesized and screened for activity in inhibiting H. armigera larval growth and AP activity. The most effective compounds in both assays proved to be hydroxamic acids and methylphosphonic acids. Compounds that incorporated both of these groups were also found to have significant potential as control agents. The most inhibitory compounds included valine methylphosphonic acid and a leucine methylphosphonic acid/hydroxamic acid derivative. The valine methylphosphonic acid compound was tested further in vitro, with the aim of producing a new active capable of restricting the viability of Helicoverpa populations on commercial crops.     

Effect of cereal type and exogenous enzyme supplementation in pig diets on odour and ammonia emissions

A 2 × 2 factorial experiment was conducted to investigate the interaction between cereal type (wheat vs. barley) and exogenous enzyme supplementation (with or without) on odour concentration and ammonia emissions in grower–finisher pigs. The enzyme supplement used contained Endo-1, 3 (4)-β-glucanase (EC 3.2.1.6) and Endo-1, 4-β-xylanase (E.C 3.2.1.8). The diets were formulated to contain similar levels of digestible energy and lysine. The experimental treatments were as follows: (1) wheat-based diet, (2) wheat-based diet containing a β-glucanase and β-xylanase mixed enzyme supplement, (3) barley-based diet and (4) barley-based diet containing a β-glucanase and β-xylanase mixed enzyme supplement. The diets were offered to the pigs for 4 weeks and this was repeated 4 times (n = 4). Odour and ammonia emissions were measured on days 9, 11, 14, 16, 21 and 23 of each experimental period. Odour samples were collected in 20-litre Nalophan bags and analysed for odour concentration using an ECOMA Yes/No Olfactometer. Ammonia concentrations were measured using Dräger tubes. There was a cereal × enzyme interaction in odour emission rates (P < 0.05) and in ammonia emissions (P < 0.01). The addition of an enzyme supplement increased odour emissions and had no effect on ammonia emissions in the barley-based diet. The enzyme supplementation had no effect on odour but decreased ammonia emissions in the wheat based diet.     

日粮中添加植酸酶和锌对断奶仔猪生产性能及其组织锌浓度的影响

通过三个试验测定日粮中植酸酶、过量的锌及两者共同对哺乳仔猪的影响。在所有的试验中,每个处理组有5～7栏,每栏有6～7头猪,当日粮中添加植酸酶时,则日粮中钙和有效磷的水平降低0.1%,锌是通过氧化锌的形式添加,试验日粮中含锌水平均为127mg/kg,本试验的周期为19～21d。在试验1中,试验采用2×3因子试验设计,两个水平的植酸酶(即0和500植酸酶单位/kg)和三水平过量的锌(即0,1000和2000mg/kg)。仔猪(5.7kg和18日龄)被随机分配采食以上日粮。试验表明,平均日增重(ADG)和平均日采食量(ADFI)随日粮中锌含量的增加而线性增加,第一阶段为(P=0.01～0.06),第二阶段为(P=0.02～0.09),整个试验阶段为(P=0.01～0.02),肉料比(G∶F)也随日粮锌含量的增加而线性增加,但仅限于第一阶段(P=0.01)。当仔猪采食1000或2000mg/kg锌时的同时添加植酸酶可降低第二阶段ADG(锌与植酸酶互作;P=0.10),但对整个试验周期内ADFI没有影响(P=0.27～0.62),并可降低第二阶段G∶F(P=0.01),及整个试验周期内G∶F(P=0.07)。随着日粮锌添加量的增加,血浆中锌含量也随之增加(Zn2,P=0.01),并且不受植酸酶添加的影响(P=0.70)。在试验2中,试验采用2×2因子试验设计,两个水平的植酸酶(即0和500植酸酶单位/kg)和两水平过量的锌(即0和2000mg/kg)。仔猪(5.2kg和18日龄)被随机分配采食以上日粮。试验表明,日粮中锌含量的增加可使第二阶段ADG和肉料比增加(P=0.02～0.09)和整个试验阶段的ADG和G∶F增加(P=0.07～0.08),但对第一阶段ADG和整个试验阶段ADFI的变化没有影响。植酸酶的添加可增加第二阶段ADG(P=0.06)和G∶F(P=0.01)。当仔猪采食2000mg/kgZn和植酸酶时,G∶F值最大(锌与植酸酶互作;P=0.01)。骨(20日龄)中锌和血浆锌(7和20日龄)随着日粮中锌的添加量的增加而增加(P=0.01),但不受植酸酶添加的影响(P=0.51～0.90)。在试验3中,仔猪(5.7kg和19日龄)被随机分配采食添加500植酸酶单位/kg的植酸酶或不添加植酸酶的基础日粮或添加500植酸酶单位/kg的植酸酶或不添加植酸酶且钙和有效磷含量降低0.10%的基础日粮。试验表明,植酸酶的添加对仔猪生产性能没有影响(P=0.21～0.81)。降低钙和有效磷的含量,可降低整个试验周期内ADG,ADFI和G∶F(P=0.02～0.08)。这些试验结果表明,日粮中添加过量的锌可增加ADG及血浆和骨中锌的浓度。日粮中植酸酶对血浆和骨中锌的浓度没有影响。